Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001225208-10-000915)

Filing Details

Accession Number:: 0001225208-10-000915
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-01-06 12:00:00
Reporting Period:: 2010-01-04

Filing Date:: 2010-01-06
Accepted Time:: 2010-01-06 13:28:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
901219	Human Genome Sciences Inc	HGSI	In Vitro & In Vivo Diagnostic Substances (2835)	223178468

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1191234	D. Susan Bateson	14200 Shady Grove Road Rockville MD 20850	Senior Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-01-04	1,000	$30.90	75,190	No	4	S	Direct
Common Stock	Disposition	2010-01-04	1,200	$30.84	73,990	No	4	S	Direct
Common Stock	Disposition	2010-01-04	1,500	$30.90	72,490	No	4	S	Direct
Common Stock	Disposition	2010-01-04	3,800	$30.89	68,690	No	4	S	Direct
Common Stock	Disposition	2010-01-04	3,832	$30.84	64,858	No	4	S	Direct
Common Stock	Disposition	2010-01-04	4,500	$30.90	60,358	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and Charles Schwab effective 12/10/09.